“It’s a Way of Reparations”: Why Henrietta Lacks Settlement Matters for Bioethics & Racial Justice
By Amy Goodman,
Democracy Now!
| 08. 07. 2023
The family of Henrietta Lacks, a Black cancer patient whose cells were taken by Johns Hopkins University Hospital without her consent in 1951, has reached a deal over the unethical use of her cells with pharmaceutical company Thermo Fisher Scientific. Henrietta Lacks’s family has denounced the racist medical system that allowed the biotech company to make billions in profit from the “HeLa” cell line, which helped produce remedies for multiple diseases, including the first polio vaccine. Details of the settlement were not made public, but the plaintiffs celebrated the lawsuit’s resolution last Tuesday, on Henrietta Lack’s birthday. For more on the case and the history of medical racism in the United States, we speak with Dorothy Roberts, director of the University of Pennsylvania Program on Race, Science and Society. She is the author of several books, including Fatal Invention: How Science, Politics, and Big Business Re-create Race in the Twenty-first Century. “What happened to Henrietta Lacks didn’t just happen to her. It’s part of a long history of experimentation and exploitation of Black people in biomedical research,” says Roberts...
Related Articles
By Editors, Nature | 08.18.2026
Shinya Yamanaka doesn’t see himself as a celebrity. But people do recognize the stem-cell researcher when he’s out for a run, often while training for a marathon, on the streets of Kyoto, Japan.
Many of them call out words of...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...